Improved Survival after Implementation of Multidisciplinary Team Meetings, Perioperative Chemotherapy, Extended Lymphnode Dissection and Laparoscopic Surgery in the Treatment of Advanced Gastric Cancer — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Improved Survival after Implementation of Multidisciplinary Team Meetings, Perioperative Chemotherapy, Extended Lymphnode Dissection and Laparoscopic Surgery in the Treatment of Advanced Gastric Cancer
Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
,
Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
,
Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
,
Department of Pathology, Akershus University Hospital, Lorenskog, Norway
,
Faculty of Medicine, Universtity of Oslo, Nydalen, Oslo, Norway
,
Department of Radiology, Akershus University Hospital, Lorenskog, Norway
,
Department of Oncology, Akershus University Hospital, Lorenskog, Norway
,
Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
,
Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
1 Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
2 Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
3 Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
4 Department of Pathology, Akershus University Hospital, Lorenskog, Norway
5 Faculty of Medicine, Universtity of Oslo, Nydalen, Oslo, Norway
6 Department of Radiology, Akershus University Hospital, Lorenskog, Norway
7 Department of Oncology, Akershus University Hospital, Lorenskog, Norway
8 Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
9 Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway
Aims : The treatment of gastric cancer has changed in the western countries during the last decade. This includes multidisciplinary team (MDT) meetings, perioperative chemotherapy, extended lymph node dissection, and laparo scopic surgery, all of which were gradually implemented at our department from 2008. The aim of the present study was to determine the effect of these changes on morbidity and survival. Material and Methods : 185 patients with gastric cancer were operated with curative intent from 2000 until 2016 in this retrospective, observational, follow-up study ; 83 before implementation of modern principles in 2008 (period 1) and 102 were treated after 2008 (period 2). Results : The resection rate (94% vs 92.8%) and mortality rates (4.8% vs 2.9%) did not differ between the two periods. In period 2, 48 patients (47.1%), received neoadjuvant chemotherapy. In 36 patients (35.3%), laparoscopic surgery with D2 lymphadenectomy was performed. There was a significantly higher yield in the number of lymph nodes in period 2 compared to period 1 (14 vs 8, p < 0.001). This is also a p parent between laparoscopic and open surgery in the second period (32 vs 10, p < 0.001). The five-year survival rate was significantly improved after the change in treatment principles with an estimated improvement from 30% to 40% between the periods (p = 0.033). Conclusion : The combined effect of MDT meetings, neoadjuvant chemotherapy, extended lymphnode dissection and laparoscopy has improved the prognosis of gastric cancer patients.
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N.D. and Kamangar, F. (2014) Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiology, Biomarkers and Prevention, 23, 700-713. https://doi.org/10.1158/1055-9965.EPI-13-1057
Cancer Registry of Norway (2017) Cancer in Norway 2016—Cancer Incidence, Mortality, Survival and Prevalence in Norway. Cancer Registry of Norway, Oslo.
Cunningham, D., Allum, W.H., Stenning, S.P., Thompson, J.N., Van der Velde, C.J.H., Nicolson, M., Scarffe, J.H., Lofts, F.J., Falk, S.J., Iveson, T.J., Smith, D.B., Langley, R.E., Verma, M., Weeden, S. and Chua, Y.J. (2006) Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. New England Journal of Medicine, 355, 11-20. https://doi.org/10.1056/NEJMoa055531
Cui, M., Xing, J.D., Yang, W., Ma, Y.Y., Yao, Z.D., Zhang, N. and Su, X.Q. (2012) D2 Dissection in Laparoscopic and Open Gastrectomy for Gastric Cancer. World Journal of Gastroenterology, 18, 833-839. http://www.wjgnet.com/1007-9327/full/v18/i8/833.htm https://doi.org/10.3748/wjg.v18.i8.833
Tamura, S., Takeno, A. and Miki, H. (2011) Lymph Node Dissection in Curative Gastrectomy for Advanced Gastric Cancer. International Journal of Surgical Oncology, 2011, Article ID: 748745. https://doi.org/10.1155/2011/748745
Songun, I., Putter, H., Kranenbarg, E.M.-K., Sasako, M. and van de Velde, C.J.H. (2010) Surgical Treatment of Gastric Cancer: 15-Year Follow-Up Results of the Randomised Nationwide Dutch D1D2 Trial. Lancet Oncology, 11, 439-449. https://doi.org/10.1016/S1470-2045(10)70070-X
Davies, A.R., Deans, D.A., Penman, I., Plevris, J.N., Fletcher, J., Wall, L., Phillips, H., Gilmour, H., Patel, D., de Beaux, A. and Paterson-Brown, S. (2006) The Multidisciplinary Team Meeting Improves Staging Accuracy and Treatment Selection for Gastro-Esophageal Cancer. Diseases of The Esophagus, 19, 496-503.
Lim, H.K., Stiven, P.N. and Aly, A. (2016) Reinterpretation of Radiological Findings in Oesophago-Gastric Multidisciplinary Meetings. ANZ Journal of Surgery, 86, 377-380. https://doi.org/10.1111/ans.12537
Coburn, N., Cosby, R., Klein, L., Malthaner, R., Marmazza, J., Mercer, C.D. and Ringash, J. (2017) Staging and Surgical Approaches in Gastric Cancer: A Clinical Practice Guideline. Current Oncology, 24, 324-331. https://doi.org/10.3747/co.24.3736
Holmebakk, T., Frykholm, G. and Viste, A. (2010) A on Behalf of the Norwegian Gastrointestinal Cancer Group (NGICG). Introducing National Guidelines on Perioperative Chemotherapy for Gastric Cancer in Norway: A Retrospective Audit. European Journal of Surgical Oncology, 36, 610-616. https://doi.org/10.1016/j.ejso.2010.05.006
Bringeland, E.A., Wasmuth, H.H., Fougner, R., Mjones, P. and Gronbech, J.E. (2014) Impact of Perioperative Chemotherapy on Oncological Outcomes after Gastric Cancer Surgery. British Journal of Surgery, 101, 1712-1722. https://doi.org/10.1002/bjs.9650
Choi, A.H., Kim, J. and Chao, J. (2015) Perioperative Chemotherapy for Resectable Gastric Cancer: Magic and Beyond. World Journal of Gastroenterology, 21, 7343-7348. http://www.wjgnet.com/1007-9327/full/v21/i24/7343.htm
Gabriel, E., Attwood, K., Narayanan, S., Brady, M., Nurkin, S., Hochwald, S. and Kukar, M. (2017) Does Neoadjuvant/Perioperative Chemotherapy Improve Overall Survival for T2N0 Gastric Adenocarsinoma? Journal of Surgical Oncology.
Xu, A.M., Huang, L., Liu, W., Gao, S., Han, W.X. and Wei, Z.J. (2014) Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE, 9, e86941.
Wu, A.W., Xu, G.W., Wang, H.Y., Ji, J.F. and Tang, J.L. (2007) Neoadjuvant Chemotherapy versus None for Resectable Gastric Cancer. The Cochrane Database of Systematic Reviews, No. 2, CD005047.
Degiuli, M., De Manzoni, G., Di Leo, A., D’Ugo, D., Galasso, E., Marelli, D., Petrioli, R., Polom, K., Roviello, F., Santullo, F. and Morino, M. (2016) Gastric Cancer: Current Status of Lymph Node Dissection. World Journal of Gastroenterology, 22, 2875-2893. https://doi.org/10.3748/wjg.v22.i10.2875
Edwards, P., Blackshaw, G.R.J.C., Lewis, W.G., Barry, J.D., Allison, M.C. and Jones, D.R.B. (2004) Prospective Comparison of D1 vs. Modified D2 Gastrectomy for Carcinoma. British Journal of Cancer, 90, 1888-1892. https://doi.org/10.1038/sj.bjc.6601790
Jiang, L., Yang, K.-H., Chen, Y., Guan, Q.-L., Zhao, P., Tian, J.-H. and Wang, Q. (2014) Systematic Review and Meta-Analysis of the Effectiveness and Safety of Extended Lymphadenectomy in Patients with Resectable Gastric Cancer. BJS, 101, 595-604. https://doi.org/10.1002/bjs.9497
Schwarz, R.E. and Smith, D.D. (2007) Clinical Impact of Lymphadenectomy Extent in Resectable Gastric Cancer of Advanced Stage. Annals of Surgical Oncology, 14, 317-328. https://doi.org/10.1245/s10434-006-9218-2
Wu, C.W., Hsiung, C.A., Lo, S.S., Hsieh, M.C., Shia, L.T. and Whang-Peng, J. (2004) Randomized Clinical Trial of Morbidity after D1 and D3 Surgery for Gastric Cancer. British Journal of Surgery, 91, 283-287. https://doi.org/10.1002/bjs.4433
Biffi, R., Botteri, E., Cenciarelli, S., Luca, F., Pozzi, S., Valvo, M., Sonzogni, A., Chiappa, A., Leal Ghezzi, T., Rotmensz, N., Bagnardi, V. and Andreoni, B. (2011) Impact on Survival of the Number of Lymph Nodes Removed in Patients with Node-Negative Gastric Cancer Submitted to Extended Lymph Node Dissection. European Journal of Surgical Oncology, 37, 305-311. https://doi.org/10.1016/j.ejso.2011.01.013
Wu, C.W., Hsiung, C.A., Lo, S.S., et al. (2006) Nodal Dissection for Patients with Gastric Cancer: A Randomised Controlled Trial. The Lancet Oncology, 7, 309-315. https://doi.org/10.1016/S1470-2045(06)70623-4
Dent, D.M., Madden, M.V. and Price, S.K. (1988) Randomized Comparison of R, and R, Gastrectomy for Gastric Carcinoma. British Journal of Surgery, 75, 110-112. https://doi.org/10.1002/bjs.1800750206
de Steur, W.O., Hartgrink, H.H., Dikken, J.L., Putter, H. and van de Velde, C.J.H. (2015) Quality Control of Lymph Node Dissection in the Dutch Gastric Cancer Trial. British Journal of Surgery, 102, 1388-1393.
Honda, M., Hiki, N., Kinoshita, T., Yabusaki, H., Nunobe, S., Terada, M., Matsuki, A., Sunagawa, H., Aizawa, M., Healy, M.A., Iwasaki, M. and Furukawa, T.A. (2016) Long-Term Outcome of Laparoscopic versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Annals of Surgery, 264, 214-222. https://doi.org/10.1097/SLA.0000000000001654
Oh, S.Y., Kwon, S., Lee, K.G., Suh, Y.S., Choe, H.N., Kong, S.H., Lee, H.J., Kim, W.H. and Yang, H.K. (2014) Outcomes of Minimally Invasive Surgery for Early Gastric Cancer Are Comparable with Those for Open Surgery: Analysis of 1,013 Minimally Invasive Surgeries at a Single Institution. Surgical Endoscopy, 28, 789-795.